| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.21e-09 | 27 | 41 | 5 | GO:0023026 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 2.01e-08 | 41 | 41 | 5 | GO:0023023 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 5.06e-08 | 49 | 41 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.31e-06 | 11 | 41 | 3 | GO:0098919 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 1.31e-06 | 11 | 41 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 2.27e-06 | 13 | 41 | 3 | GO:0098879 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.82e-05 | 32 | 41 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | antigen binding | 4.20e-05 | 190 | 41 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.72e-05 | 42 | 41 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | KCNK2 SLC37A1 MFSD9 SLC16A11 SLC9A4 SLC9A2 CLCN2 CLCN3 CLDN2 KCNK10 | 1.04e-04 | 1180 | 41 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.16e-04 | 123 | 41 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 1.66e-04 | 52 | 41 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.81e-04 | 138 | 41 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | transporter activity | KCNK2 SLC37A1 MFSD9 SLC16A11 SLC9A4 SLC9A2 CLCN2 CLCN3 CLDN2 KCNK10 | 2.15e-04 | 1289 | 41 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | CD4 receptor binding | 2.24e-04 | 11 | 41 | 2 | GO:0042609 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.24e-04 | 11 | 41 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | guanylate kinase activity | 2.24e-04 | 11 | 41 | 2 | GO:0004385 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.35e-04 | 296 | 41 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 3.69e-04 | 14 | 41 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.75e-04 | 167 | 41 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | peptide binding | 4.65e-04 | 318 | 41 | 5 | GO:0042277 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 4.85e-04 | 16 | 41 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 4.85e-04 | 16 | 41 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.20e-04 | 182 | 41 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.41e-04 | 184 | 41 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.49e-04 | 17 | 41 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 6.13e-04 | 81 | 41 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 6.88e-04 | 19 | 41 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 6.88e-04 | 19 | 41 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 6.88e-04 | 19 | 41 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 7.63e-04 | 20 | 41 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 8.05e-04 | 758 | 41 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 1.01e-03 | 23 | 41 | 2 | GO:0050145 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.40e-03 | 27 | 41 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 1.40e-03 | 27 | 41 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 1.84e-03 | 31 | 41 | 2 | GO:0030247 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 2.81e-03 | 477 | 41 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 3.21e-03 | 41 | 41 | 2 | GO:0016776 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.52e-03 | 43 | 41 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 4.19e-03 | 47 | 41 | 2 | GO:0019205 | |
| GeneOntologyMolecularFunction | channel activity | 4.23e-03 | 525 | 41 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.27e-03 | 526 | 41 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.69e-03 | 165 | 41 | 3 | GO:0140375 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.78e-03 | 334 | 41 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.18e-03 | 171 | 41 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.28e-03 | 793 | 41 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | channel regulator activity | 5.44e-03 | 174 | 41 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 5.70e-03 | 177 | 41 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 6.11e-03 | 57 | 41 | 2 | GO:0015459 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.35e-02 | 86 | 41 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.43e-02 | 459 | 41 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.49e-02 | 465 | 41 | 4 | GO:0046873 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.18e-10 | 16 | 42 | 5 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.18e-10 | 16 | 42 | 5 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 5.44e-10 | 21 | 42 | 5 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 5.44e-10 | 21 | 42 | 5 | GO:0002501 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.29e-09 | 32 | 42 | 5 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 9.85e-09 | 36 | 42 | 5 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.31e-08 | 38 | 42 | 5 | GO:0002504 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 4.39e-08 | 48 | 42 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.16e-07 | 58 | 42 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.54e-07 | 76 | 42 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 9.00e-06 | 139 | 42 | 5 | GO:0019882 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 1.21e-05 | 3 | 42 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 3.97e-05 | 94 | 42 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 5.25e-05 | 101 | 42 | 4 | GO:0030641 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immune response to tumor cell | 8.45e-05 | 7 | 42 | 2 | GO:0002842 | |
| GeneOntologyBiologicalProcess | regulation of pH | 1.03e-04 | 120 | 42 | 4 | GO:0006885 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.04e-04 | 232 | 42 | 5 | GO:0071805 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 1.44e-04 | 9 | 42 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.19e-04 | 272 | 42 | 5 | GO:0006813 | |
| GeneOntologyBiologicalProcess | GDP metabolic process | 2.20e-04 | 11 | 42 | 2 | GO:0046710 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of epithelial cell apical/basal polarity | 2.24e-04 | 58 | 42 | 3 | GO:0045197 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DLG1 DLG2 DLG3 HLA-DPB1 HLA-DRB1 CLDN2 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 2.61e-04 | 1077 | 42 | 9 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 2.71e-04 | 447 | 42 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of bipolar cell polarity | 2.86e-04 | 63 | 42 | 3 | GO:0061245 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of apical/basal cell polarity | 2.86e-04 | 63 | 42 | 3 | GO:0035088 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 2.95e-04 | 290 | 42 | 5 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 3.09e-04 | 458 | 42 | 6 | GO:0050863 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immune response to tumor cell | 3.63e-04 | 14 | 42 | 2 | GO:0002840 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 4.24e-04 | 486 | 42 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 4.43e-04 | 317 | 42 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | stabilization of membrane potential | 5.40e-04 | 17 | 42 | 2 | GO:0030322 | |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 5.40e-04 | 17 | 42 | 2 | GO:0002424 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 5.40e-04 | 17 | 42 | 2 | GO:0098880 | |
| GeneOntologyBiologicalProcess | receptor clustering | 6.44e-04 | 83 | 42 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 8.29e-04 | 21 | 42 | 2 | GO:0002468 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 8.98e-04 | 1017 | 42 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.06e-03 | 385 | 42 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.07e-03 | 580 | 42 | 6 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.11e-03 | 389 | 42 | 5 | GO:0022409 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.14e-03 | 101 | 42 | 3 | GO:0097120 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 1.38e-03 | 27 | 42 | 2 | GO:0098719 | |
| GeneOntologyBiologicalProcess | adaptive immune response | 1.39e-03 | 838 | 42 | 7 | GO:0002250 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.43e-03 | 614 | 42 | 6 | GO:0051249 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 1.48e-03 | 28 | 42 | 2 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 1.48e-03 | 28 | 42 | 2 | GO:0002839 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.61e-03 | 423 | 42 | 5 | GO:0002696 | |
| GeneOntologyBiologicalProcess | GMP metabolic process | 2.05e-03 | 33 | 42 | 2 | GO:0046037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 2.09e-03 | 449 | 42 | 5 | GO:0050867 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.20e-10 | 17 | 40 | 5 | GO:0042613 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.26e-09 | 26 | 40 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.16e-09 | 35 | 40 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 3.19e-08 | 48 | 40 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | late endosome membrane | 4.41e-08 | 179 | 40 | 7 | GO:0031902 | |
| GeneOntologyCellularComponent | membrane protein complex | KCNK2 SNF8 DLG1 DLG2 DLG3 C7 NOX1 CLCN2 APOO HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 KCNK10 | 4.57e-08 | 1498 | 40 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.14e-08 | 110 | 40 | 6 | GO:0030134 | |
| GeneOntologyCellularComponent | transport vesicle membrane | DLG1 DLG2 CLCN3 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 7.06e-08 | 293 | 40 | 8 | GO:0030658 |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.39e-07 | 64 | 40 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | KCNK2 DLG1 DLG2 DLG3 C7 NOX1 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 1.67e-07 | 785 | 40 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 4.02e-07 | 79 | 40 | 5 | GO:0030669 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 1.37e-06 | 101 | 40 | 5 | GO:0045334 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 2.29e-06 | 112 | 40 | 5 | GO:0032588 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | KCNK2 SLC37A1 LMAN1L DLG1 SLC16A11 APOO HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GUCY2D | 3.29e-06 | 1293 | 40 | 12 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | KCNK2 SLC37A1 LMAN1L DLG1 SLC16A11 APOO HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GUCY2D | 3.45e-06 | 1299 | 40 | 12 | GO:0098827 |
| GeneOntologyCellularComponent | late endosome | 3.88e-06 | 348 | 40 | 7 | GO:0005770 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | KCNK2 SLC37A1 LMAN1L DLG1 SLC16A11 APOO HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 GUCY2D | 4.31e-06 | 1327 | 40 | 12 | GO:0042175 |
| GeneOntologyCellularComponent | transport vesicle | DLG1 DLG2 CLCN3 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 5.23e-06 | 519 | 40 | 8 | GO:0030133 |
| GeneOntologyCellularComponent | Golgi membrane | LMAN1L CLCN3 APOO GOLT1A HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 6.88e-06 | 721 | 40 | 9 | GO:0000139 |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 8.67e-06 | 147 | 40 | 5 | GO:0030665 | |
| GeneOntologyCellularComponent | autolysosome membrane | 2.14e-05 | 4 | 40 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.37e-05 | 306 | 40 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.44e-05 | 462 | 40 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.44e-05 | 462 | 40 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | vacuolar membrane | 4.41e-05 | 507 | 40 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.04e-05 | 212 | 40 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 5.39e-05 | 215 | 40 | 5 | GO:0030662 | |
| GeneOntologyCellularComponent | coated vesicle | 5.86e-05 | 360 | 40 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.36e-05 | 384 | 40 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 8.55e-05 | 237 | 40 | 5 | GO:0030136 | |
| GeneOntologyCellularComponent | immunological synapse | 1.13e-04 | 49 | 40 | 3 | GO:0001772 | |
| GeneOntologyCellularComponent | endosome membrane | 1.29e-04 | 602 | 40 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SNF8 DLG1 DLG2 SLC9A4 CLCN3 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 1.33e-04 | 1307 | 40 | 10 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SNF8 DLG1 DLG2 SLC9A4 CLCN3 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 1.49e-04 | 1325 | 40 | 10 | GO:0012506 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.82e-04 | 443 | 40 | 6 | GO:0098791 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.45e-04 | 320 | 40 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | autolysosome | 5.36e-04 | 18 | 40 | 2 | GO:0044754 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.47e-04 | 354 | 40 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 7.36e-04 | 378 | 40 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 7.36e-04 | 378 | 40 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | lysosome | 7.85e-04 | 811 | 40 | 7 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 7.85e-04 | 811 | 40 | 7 | GO:0000323 | |
| GeneOntologyCellularComponent | neuronal cell body | 9.32e-04 | 835 | 40 | 7 | GO:0043025 | |
| GeneOntologyCellularComponent | astrocyte projection | 1.04e-03 | 25 | 40 | 2 | GO:0097449 | |
| GeneOntologyCellularComponent | secondary lysosome | 1.13e-03 | 26 | 40 | 2 | GO:0005767 | |
| GeneOntologyCellularComponent | side of membrane | 1.22e-03 | 875 | 40 | 7 | GO:0098552 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.28e-03 | 112 | 40 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | endosome | SNF8 NOX1 CLCN3 HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 | 1.43e-03 | 1167 | 40 | 8 | GO:0005768 |
| GeneOntologyCellularComponent | vacuole | 1.56e-03 | 913 | 40 | 7 | GO:0005773 | |
| GeneOntologyCellularComponent | cell body | 1.73e-03 | 929 | 40 | 7 | GO:0044297 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.01e-03 | 131 | 40 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.26e-03 | 487 | 40 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | tight junction | 2.37e-03 | 139 | 40 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.07e-03 | 523 | 40 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.35e-03 | 157 | 40 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | apical junction complex | 3.41e-03 | 158 | 40 | 3 | GO:0043296 | |
| GeneOntologyCellularComponent | glial cell projection | 3.65e-03 | 47 | 40 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | transporter complex | 3.81e-03 | 550 | 40 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.97e-03 | 49 | 40 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 4.83e-03 | 179 | 40 | 3 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 4.83e-03 | 179 | 40 | 3 | GO:0030672 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 5.15e-03 | 56 | 40 | 2 | GO:0099091 | |
| GeneOntologyCellularComponent | apical part of cell | 5.20e-03 | 592 | 40 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | dendrite | 5.47e-03 | 858 | 40 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 5.53e-03 | 860 | 40 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | axon | 6.55e-03 | 891 | 40 | 6 | GO:0030424 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.66e-03 | 201 | 40 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 7.32e-03 | 405 | 40 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | adherens junction | 7.71e-03 | 212 | 40 | 3 | GO:0005912 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 8.04e-03 | 1228 | 40 | 7 | GO:0036477 | |
| GeneOntologyCellularComponent | perikaryon | 8.85e-03 | 223 | 40 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.06e-02 | 451 | 40 | 4 | GO:0014069 | |
| GeneOntologyCellularComponent | main axon | 1.26e-02 | 89 | 40 | 2 | GO:0044304 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.28e-02 | 477 | 40 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.31e-02 | 91 | 40 | 2 | GO:0008076 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.53e-02 | 503 | 40 | 4 | GO:0099572 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.69e-02 | 104 | 40 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.74e-02 | 523 | 40 | 4 | GO:0098984 | |
| Domain | MHC_II_b_N | 2.50e-12 | 8 | 42 | 5 | PD000328 | |
| Domain | MHC_II_beta | 5.63e-12 | 9 | 42 | 5 | PF00969 | |
| Domain | MHC_II_b_N | 5.63e-12 | 9 | 42 | 5 | IPR000353 | |
| Domain | MHC_II_beta | 5.63e-12 | 9 | 42 | 5 | SM00921 | |
| Domain | MHC_II_a/b_N | 8.86e-11 | 14 | 42 | 5 | IPR014745 | |
| Domain | - | 8.86e-11 | 14 | 42 | 5 | 3.10.320.10 | |
| Domain | MHC_I/II-like_Ag-recog | 2.14e-08 | 38 | 42 | 5 | IPR011162 | |
| Domain | EamA_dom | 2.17e-08 | 14 | 42 | 4 | IPR000620 | |
| Domain | EamA | 2.17e-08 | 14 | 42 | 4 | PF00892 | |
| Domain | MAGUK_N_PEST | 4.22e-08 | 4 | 42 | 3 | PF10608 | |
| Domain | PDZ_assoc | 4.22e-08 | 4 | 42 | 3 | PF10600 | |
| Domain | MAGUK_N_PEST | 4.22e-08 | 4 | 42 | 3 | SM01277 | |
| Domain | DLG1 | 4.22e-08 | 4 | 42 | 3 | IPR016313 | |
| Domain | DLG1_PEST_dom | 4.22e-08 | 4 | 42 | 3 | IPR019590 | |
| Domain | PDZ_assoc | 4.22e-08 | 4 | 42 | 3 | IPR019583 | |
| Domain | C1-set | 1.31e-07 | 54 | 42 | 5 | PF07654 | |
| Domain | IGc1 | 1.58e-07 | 56 | 42 | 5 | SM00407 | |
| Domain | Ig_C1-set | 1.89e-07 | 58 | 42 | 5 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.89e-07 | 58 | 42 | 5 | IPR003006 | |
| Domain | IG_MHC | 2.24e-07 | 60 | 42 | 5 | PS00290 | |
| Domain | 2pore_dom_K_chnl_TREK | 4.94e-06 | 2 | 42 | 2 | IPR003976 | |
| Domain | Na/H_exchanger_2 | 4.94e-06 | 2 | 42 | 2 | IPR001953 | |
| Domain | Guanylate_kinase_CS | 5.80e-06 | 16 | 42 | 3 | IPR020590 | |
| Domain | NEXCaM_BD | 1.48e-05 | 3 | 42 | 2 | PF16644 | |
| Domain | NHE_CaM-bd | 1.48e-05 | 3 | 42 | 2 | IPR032103 | |
| Domain | GUANYLATE_KINASE_2 | 1.81e-05 | 23 | 42 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.81e-05 | 23 | 42 | 3 | PS00856 | |
| Domain | Guanylate_kin | 2.65e-05 | 26 | 42 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.65e-05 | 26 | 42 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.65e-05 | 26 | 42 | 3 | IPR008144 | |
| Domain | GuKc | 2.65e-05 | 26 | 42 | 3 | SM00072 | |
| Domain | DMAP_binding | 4.92e-05 | 5 | 42 | 2 | PF06464 | |
| Domain | DMAP_binding | 7.36e-05 | 6 | 42 | 2 | SM01137 | |
| Domain | DMAP1-bd | 7.36e-05 | 6 | 42 | 2 | IPR010506 | |
| Domain | Cl-channel_core | 1.76e-04 | 9 | 42 | 2 | IPR014743 | |
| Domain | NaH_exchanger | 1.76e-04 | 9 | 42 | 2 | IPR004709 | |
| Domain | - | 1.76e-04 | 9 | 42 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.76e-04 | 9 | 42 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.76e-04 | 9 | 42 | 2 | IPR001807 | |
| Domain | Cation/H_exchanger_CPA1 | 2.68e-04 | 11 | 42 | 2 | IPR018422 | |
| Domain | Na_H_Exchanger | 4.42e-04 | 14 | 42 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 4.42e-04 | 14 | 42 | 2 | IPR006153 | |
| Domain | 2pore_dom_K_chnl | 5.09e-04 | 15 | 42 | 2 | IPR003280 | |
| Domain | CBS | 5.81e-04 | 16 | 42 | 2 | SM00116 | |
| Domain | MFS | 6.89e-04 | 77 | 42 | 3 | IPR011701 | |
| Domain | MFS_1 | 6.89e-04 | 77 | 42 | 3 | PF07690 | |
| Domain | CBS_dom | 9.14e-04 | 20 | 42 | 2 | IPR000644 | |
| Domain | CBS | 9.14e-04 | 20 | 42 | 2 | PF00571 | |
| Domain | CBS | 9.14e-04 | 20 | 42 | 2 | PS51371 | |
| Domain | K_chnl_dom | 1.01e-03 | 21 | 42 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 1.01e-03 | 21 | 42 | 2 | PF07885 | |
| Domain | MFS | 1.83e-03 | 108 | 42 | 3 | PS50850 | |
| Domain | AMP-binding | 2.06e-03 | 30 | 42 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 2.06e-03 | 30 | 42 | 2 | IPR000873 | |
| Domain | MFS_dom | 3.38e-03 | 134 | 42 | 3 | IPR020846 | |
| Domain | PDZ | 3.90e-03 | 141 | 42 | 3 | PF00595 | |
| Domain | PDZ | 4.46e-03 | 148 | 42 | 3 | SM00228 | |
| Domain | - | 4.63e-03 | 150 | 42 | 3 | 2.30.42.10 | |
| Domain | IG_LIKE | 4.69e-03 | 491 | 42 | 5 | PS50835 | |
| Domain | PDZ | 4.72e-03 | 151 | 42 | 3 | PS50106 | |
| Domain | PDZ | 4.81e-03 | 152 | 42 | 3 | IPR001478 | |
| Domain | Ig-like_dom | 5.20e-03 | 503 | 42 | 5 | IPR007110 | |
| Domain | SH3_1 | 5.94e-03 | 164 | 42 | 3 | PF00018 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 7.58e-11 | 15 | 29 | 5 | M47604 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 7.58e-11 | 15 | 29 | 5 | M47588 | |
| Pathway | REACTOME_PD_1_SIGNALING | 2.44e-09 | 28 | 29 | 5 | M18810 | |
| Pathway | KEGG_ASTHMA | 3.52e-09 | 30 | 29 | 5 | M13950 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 4.72e-09 | 11 | 29 | 4 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 4.72e-09 | 11 | 29 | 4 | M22048 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 1.02e-08 | 13 | 29 | 4 | M18928 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.07e-08 | 37 | 29 | 5 | M18615 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.41e-08 | 39 | 29 | 5 | M16523 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.43e-08 | 14 | 29 | 4 | M22023 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.43e-08 | 14 | 29 | 4 | M1473 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 1.43e-08 | 14 | 29 | 4 | M10765 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.82e-08 | 41 | 29 | 5 | M13519 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 1.94e-08 | 15 | 29 | 4 | M7298 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.34e-08 | 43 | 29 | 5 | M12617 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 4.13e-08 | 48 | 29 | 5 | M615 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 6.23e-08 | 52 | 29 | 5 | M13103 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 1.03e-07 | 22 | 29 | 4 | M1467 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 1.03e-07 | 22 | 29 | 4 | M6327 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 1.24e-07 | 23 | 29 | 4 | M6705 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 2.50e-07 | 133 | 29 | 6 | M16476 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.83e-07 | 70 | 29 | 5 | M12294 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 3.25e-07 | 139 | 29 | 6 | M4741 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 3.26e-07 | 72 | 29 | 5 | M3126 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 3.31e-07 | 29 | 29 | 4 | M6910 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 3.74e-07 | 74 | 29 | 5 | M17386 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 8.92e-07 | 88 | 29 | 5 | M16004 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.52e-06 | 98 | 29 | 5 | M965 | |
| Pathway | REACTOME_TCR_SIGNALING | 4.87e-06 | 124 | 29 | 5 | M15381 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 5.27e-06 | 126 | 29 | 5 | M705 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 6.26e-06 | 18 | 29 | 3 | M22001 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 8.72e-06 | 20 | 29 | 3 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.02e-05 | 21 | 29 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.02e-05 | 21 | 29 | 3 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.17e-05 | 22 | 29 | 3 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.35e-05 | 23 | 29 | 3 | M27949 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.48e-05 | 28 | 29 | 3 | M837 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 2.86e-05 | 87 | 29 | 4 | M6856 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 3.12e-05 | 89 | 29 | 4 | M39398 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.90e-05 | 35 | 29 | 3 | MM15109 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 8.53e-05 | 7 | 29 | 2 | M27378 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 9.80e-05 | 44 | 29 | 3 | M27934 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.46e-04 | 9 | 29 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.46e-04 | 9 | 29 | 2 | MM15079 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.82e-04 | 10 | 29 | 2 | M10272 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.13e-04 | 273 | 29 | 5 | M983 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 2.22e-04 | 11 | 29 | 2 | MM14547 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.66e-04 | 12 | 29 | 2 | MM15142 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 2.66e-04 | 12 | 29 | 2 | M1071 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.43e-04 | 67 | 29 | 3 | MM15327 | |
| Pathway | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | 4.82e-04 | 16 | 29 | 2 | MM14808 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.46e-04 | 335 | 29 | 5 | MM14503 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | 6.84e-04 | 19 | 29 | 2 | MM14807 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 6.84e-04 | 19 | 29 | 2 | M27452 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 6.84e-04 | 19 | 29 | 2 | MM15194 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.39e-04 | 87 | 29 | 3 | M27617 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 7.59e-04 | 20 | 29 | 2 | MM15485 | |
| Pathway | REACTOME_PD_1_SIGNALING | 7.59e-04 | 20 | 29 | 2 | MM15001 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 8.38e-04 | 21 | 29 | 2 | M27736 | |
| Pathway | WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX | 8.38e-04 | 21 | 29 | 2 | M39876 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 9.25e-04 | 94 | 29 | 3 | M2843 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.37e-03 | 411 | 29 | 5 | M735 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.39e-03 | 27 | 29 | 2 | MM14809 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.72e-03 | 30 | 29 | 2 | M18193 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.95e-03 | 32 | 29 | 2 | MM15326 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.95e-03 | 32 | 29 | 2 | MM15143 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.07e-03 | 33 | 29 | 2 | M39875 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 2.30e-03 | 129 | 29 | 3 | M39693 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 2.45e-03 | 132 | 29 | 3 | M48110 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.89e-03 | 39 | 29 | 2 | MM15914 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.14e-03 | 144 | 29 | 3 | MM14501 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 5.87e-03 | 56 | 29 | 2 | M27616 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 6.32e-03 | 185 | 29 | 3 | M39718 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 6.41e-03 | 367 | 29 | 4 | M48346 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 8.08e-03 | 66 | 29 | 2 | MM14990 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.38e-03 | 205 | 29 | 3 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 9.07e-03 | 211 | 29 | 3 | MM14502 | |
| Pubmed | 1.20e-14 | 6 | 42 | 5 | 17153701 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 1.20e-14 | 6 | 42 | 5 | 14508706 | |
| Pubmed | 4.21e-14 | 7 | 42 | 5 | 18569076 | ||
| Pubmed | 5.03e-13 | 10 | 42 | 5 | 12956878 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 1.84e-12 | 4 | 42 | 4 | 12144077 | |
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 9056918 | ||
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 1.84e-12 | 4 | 42 | 4 | 3476943 | |
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 1.84e-12 | 4 | 42 | 4 | 17101974 | |
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 26740600 | ||
| Pubmed | 1.84e-12 | 4 | 42 | 4 | 18520346 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 3.99e-12 | 14 | 42 | 5 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 3.99e-12 | 14 | 42 | 5 | 1869305 | |
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 1967269 | ||
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 9079699 | ||
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 8376762 | ||
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 3489470 | ||
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 5.97e-12 | 15 | 42 | 5 | 22860026 | |
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 10729169 | ||
| Pubmed | 5.97e-12 | 15 | 42 | 5 | 7602119 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 8.68e-12 | 16 | 42 | 5 | 2846691 | |
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 8.68e-12 | 16 | 42 | 5 | 2543930 | |
| Pubmed | 8.68e-12 | 16 | 42 | 5 | 17959659 | ||
| Pubmed | 8.68e-12 | 16 | 42 | 5 | 1978941 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 12209103 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 23152536 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 17411376 | ||
| Pubmed | HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. | 9.17e-12 | 5 | 42 | 4 | 17559577 | |
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 9.17e-12 | 5 | 42 | 4 | 17507489 | |
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 7734415 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 11782380 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 17910142 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 9.17e-12 | 5 | 42 | 4 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 9.17e-12 | 5 | 42 | 4 | 12144632 | |
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 16973583 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 9.17e-12 | 5 | 42 | 4 | 17182961 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 9.17e-12 | 5 | 42 | 4 | 12202216 | |
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 9.17e-12 | 5 | 42 | 4 | 1970352 | |
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 7645219 | ||
| Pubmed | 9.17e-12 | 5 | 42 | 4 | 12392858 | ||
| Pubmed | 1.70e-11 | 18 | 42 | 5 | 11118314 | ||
| Pubmed | 1.70e-11 | 18 | 42 | 5 | 10661406 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 1.70e-11 | 18 | 42 | 5 | 19620308 | |
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 11082517 | ||
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 15896200 | ||
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 11997714 | ||
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 18305173 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 2.75e-11 | 6 | 42 | 4 | 19235017 | |
| Pubmed | 2.75e-11 | 6 | 42 | 4 | 15902698 | ||
| Pubmed | 3.07e-11 | 20 | 42 | 5 | 7541827 | ||
| Pubmed | 3.07e-11 | 20 | 42 | 5 | 12427289 | ||
| Pubmed | 4.03e-11 | 21 | 42 | 5 | 8084338 | ||
| Pubmed | 4.03e-11 | 21 | 42 | 5 | 21778700 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 6.41e-11 | 7 | 42 | 4 | 12230470 | |
| Pubmed | 6.41e-11 | 7 | 42 | 4 | 1905983 | ||
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 6.41e-11 | 7 | 42 | 4 | 18846964 | |
| Pubmed | Crystal structure of HLA-DP2 and implications for chronic beryllium disease. | 6.41e-11 | 7 | 42 | 4 | 20356827 | |
| Pubmed | 6.41e-11 | 7 | 42 | 4 | 20307907 | ||
| Pubmed | 6.65e-11 | 23 | 42 | 5 | 19770068 | ||
| Pubmed | 8.39e-11 | 24 | 42 | 5 | 18945465 | ||
| Pubmed | 1.28e-10 | 8 | 42 | 4 | 17106278 | ||
| Pubmed | 1.28e-10 | 8 | 42 | 4 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 1.28e-10 | 8 | 42 | 4 | 16405603 | |
| Pubmed | 1.28e-10 | 8 | 42 | 4 | 12296785 | ||
| Pubmed | 1.28e-10 | 8 | 42 | 4 | 23729440 | ||
| Pubmed | 1.30e-10 | 26 | 42 | 5 | 11827988 | ||
| Pubmed | Interactions of viral protein U (Vpu) with cellular factors. | 1.59e-10 | 27 | 42 | 5 | 20012522 | |
| Pubmed | 2.30e-10 | 9 | 42 | 4 | 24505475 | ||
| Pubmed | 2.30e-10 | 9 | 42 | 4 | 23170932 | ||
| Pubmed | 3.33e-10 | 31 | 42 | 5 | 11048639 | ||
| Pubmed | Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. | 3.33e-10 | 31 | 42 | 5 | 21922073 | |
| Pubmed | 3.84e-10 | 10 | 42 | 4 | 8450224 | ||
| Pubmed | 3.84e-10 | 10 | 42 | 4 | 15784911 | ||
| Pubmed | 3.95e-10 | 32 | 42 | 5 | 19449444 | ||
| Pubmed | 6.02e-10 | 11 | 42 | 4 | 21085635 | ||
| Pubmed | 6.02e-10 | 11 | 42 | 4 | 22808111 | ||
| Pubmed | Diversity associated with the second expressed HLA-DRB locus in the human population. | 1.64e-09 | 3 | 42 | 3 | 9162096 | |
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 1.64e-09 | 3 | 42 | 3 | 12358860 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 3099214 | ||
| Pubmed | Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. | 1.64e-09 | 3 | 42 | 3 | 8462990 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 2471740 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 3466180 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 1428007 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 20371654 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 22531795 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 1.64e-09 | 3 | 42 | 3 | 15730527 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 20193583 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 7652736 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 1.64e-09 | 3 | 42 | 3 | 16815190 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 10609818 | ||
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 1.64e-09 | 3 | 42 | 3 | 2511168 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 8016840 | ||
| Pubmed | Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. | 1.64e-09 | 3 | 42 | 3 | 8775462 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 21569485 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 1.64e-09 | 3 | 42 | 3 | 2023919 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 16441501 | ||
| Pubmed | A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. | 1.64e-09 | 3 | 42 | 3 | 12008082 | |
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 1.64e-09 | 3 | 42 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 1.64e-09 | 3 | 42 | 3 | 12121280 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 19811438 | ||
| Interaction | MS4A1 interactions | 5.05e-06 | 59 | 39 | 4 | int:MS4A1 | |
| Interaction | GUCY1A2 interactions | 5.36e-06 | 18 | 39 | 3 | int:GUCY1A2 | |
| Interaction | GLS2 interactions | 1.32e-05 | 24 | 39 | 3 | int:GLS2 | |
| Interaction | ATP1B1 interactions | 1.69e-05 | 167 | 39 | 5 | int:ATP1B1 | |
| Interaction | KCNJ12 interactions | 2.12e-05 | 28 | 39 | 3 | int:KCNJ12 | |
| Interaction | CRIPT interactions | 2.12e-05 | 28 | 39 | 3 | int:CRIPT | |
| Interaction | AOAH interactions | 2.18e-05 | 4 | 39 | 2 | int:AOAH | |
| Interaction | CACNG2 interactions | 3.51e-05 | 33 | 39 | 3 | int:CACNG2 | |
| Interaction | ANXA11 interactions | 4.11e-05 | 100 | 39 | 4 | int:ANXA11 | |
| Interaction | DLGAP2 interactions | 5.84e-05 | 39 | 39 | 3 | int:DLGAP2 | |
| Interaction | KCNJ2 interactions | 7.30e-05 | 42 | 39 | 3 | int:KCNJ2 | |
| Interaction | HLA-G interactions | 7.84e-05 | 118 | 39 | 4 | int:HLA-G | |
| Interaction | DLGAP3 interactions | 8.40e-05 | 44 | 39 | 3 | int:DLGAP3 | |
| Interaction | HLA-DRB1 interactions | 9.21e-05 | 123 | 39 | 4 | int:HLA-DRB1 | |
| Interaction | SCN5A interactions | 1.02e-04 | 47 | 39 | 3 | int:SCN5A | |
| Interaction | HLA-DQA1 interactions | 1.32e-04 | 135 | 39 | 4 | int:HLA-DQA1 | |
| Interaction | LIN7A interactions | 2.02e-04 | 59 | 39 | 3 | int:LIN7A | |
| Interaction | CNKSR2 interactions | 2.82e-04 | 66 | 39 | 3 | int:CNKSR2 | |
| Interaction | KCNA4 interactions | 3.08e-04 | 68 | 39 | 3 | int:KCNA4 | |
| Interaction | CHP2 interactions | 3.27e-04 | 14 | 39 | 2 | int:CHP2 | |
| Interaction | FZD7 interactions | 4.44e-04 | 77 | 39 | 3 | int:FZD7 | |
| Interaction | HLA-E interactions | 4.79e-04 | 79 | 39 | 3 | int:HLA-E | |
| Interaction | MPZL2 interactions | 5.47e-04 | 18 | 39 | 2 | int:MPZL2 | |
| Interaction | DLG2 interactions | 5.53e-04 | 83 | 39 | 3 | int:DLG2 | |
| Interaction | ATP2B2 interactions | 5.68e-04 | 198 | 39 | 4 | int:ATP2B2 | |
| Interaction | FZD4 interactions | 6.11e-04 | 19 | 39 | 2 | int:FZD4 | |
| Interaction | GRIA1 interactions | 6.14e-04 | 86 | 39 | 3 | int:GRIA1 | |
| Interaction | MAPK12 interactions | 6.14e-04 | 86 | 39 | 3 | int:MAPK12 | |
| Interaction | KCNJ4 interactions | 6.78e-04 | 20 | 39 | 2 | int:KCNJ4 | |
| Interaction | TMEM131L interactions | 7.71e-04 | 93 | 39 | 3 | int:TMEM131L | |
| Interaction | GRIN2A interactions | 7.71e-04 | 93 | 39 | 3 | int:GRIN2A | |
| Interaction | NLGN1 interactions | 8.23e-04 | 22 | 39 | 2 | int:NLGN1 | |
| Interaction | SCN4A interactions | 8.97e-04 | 98 | 39 | 3 | int:SCN4A | |
| Cytoband | 6p21.3 | 3.32e-06 | 250 | 42 | 5 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 6.00e-05 | 82 | 42 | 3 | chr2q12 | |
| Cytoband | 2q12.1 | 1.38e-04 | 19 | 42 | 2 | 2q12.1 | |
| Cytoband | 17p13.1 | 1.77e-04 | 118 | 42 | 3 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 5.33e-04 | 172 | 42 | 3 | chrXq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.92e-03 | 346 | 42 | 3 | chr17p13 | |
| GeneFamily | C1-set domain containing | 6.03e-09 | 42 | 29 | 5 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 7.68e-09 | 44 | 29 | 5 | 588 | |
| GeneFamily | Solute carriers | SLC35G5 SLC37A1 SLC16A11 SLC9A4 SLC9A2 SLC35G6 SLC35G3 SLC35G4 | 1.39e-07 | 395 | 29 | 8 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 9.41e-06 | 26 | 29 | 3 | 904 | |
| GeneFamily | Chloride voltage-gated channels | 1.11e-04 | 10 | 29 | 2 | 302 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 2.57e-04 | 15 | 29 | 2 | 277 | |
| GeneFamily | PDZ domain containing | 1.81e-03 | 152 | 29 | 3 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.98e-03 | 181 | 29 | 3 | 694 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 3.34e-08 | 21 | 42 | 4 | M41167 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.14e-07 | 73 | 42 | 5 | M11428 | |
| Coexpression | UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN | 8.33e-07 | 12 | 42 | 3 | M48300 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 6.72e-06 | 76 | 42 | 4 | M4551 | |
| Coexpression | HAY_BONE_MARROW_DENDRITIC_CELL | 1.55e-05 | 197 | 42 | 5 | M39194 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_NK_CELL_UP | 2.50e-05 | 5 | 42 | 2 | M48287 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES | 3.10e-05 | 38 | 42 | 3 | M39297 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 3.63e-05 | 40 | 42 | 3 | M41037 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 1.23e-04 | 60 | 42 | 3 | M40971 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL | 1.23e-04 | 60 | 42 | 3 | M39155 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_VEIN_ENDOTHELIAL_CELL_AGEING | 1.64e-04 | 12 | 42 | 2 | MM3776 | |
| Coexpression | GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS | 1.93e-04 | 13 | 42 | 2 | M16720 | |
| Coexpression | DCA_UP.V1_UP | 2.23e-04 | 186 | 42 | 4 | M2762 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MYELOID_CELLS | 2.48e-04 | 76 | 42 | 3 | M40302 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES | 2.88e-04 | 80 | 42 | 3 | M39282 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_UP | 2.93e-04 | 200 | 42 | 4 | M3423 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-07 | 156 | 40 | 5 | 03f3c5ffb27758fe63797143fcc938f9e8a4e10d | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 4.95e-07 | 175 | 40 | 5 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 6.52e-07 | 185 | 40 | 5 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 6.52e-07 | 185 | 40 | 5 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-07 | 199 | 40 | 5 | f5c8ad751d21ea0b199a02846faecd04bf100033 | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.36e-06 | 122 | 40 | 4 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.31e-06 | 139 | 40 | 4 | 4f4b447e85dda69058d9edbcfe37e55751dd90a6 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.31e-06 | 139 | 40 | 4 | 1cc48af58a2443db3c6798080b9c4bc70000cf87 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.27e-05 | 160 | 40 | 4 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 160 | 40 | 4 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 1.34e-05 | 162 | 40 | 4 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 165 | 40 | 4 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 166 | 40 | 4 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 168 | 40 | 4 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 169 | 40 | 4 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 169 | 40 | 4 | 4de0c60f3c163b7823f739ebda4e0afc68346628 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 1.65e-05 | 171 | 40 | 4 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.65e-05 | 171 | 40 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.65e-05 | 171 | 40 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-05 | 176 | 40 | 4 | fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.89e-05 | 177 | 40 | 4 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | VE-mono2-|VE / Condition, Cell_class and T cell subcluster | 2.02e-05 | 180 | 40 | 4 | 188e7c65e9a86771f89029b18dfb3216b2c9d7d7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 180 | 40 | 4 | f24d4cbba4cb50fce3b3d9c4629aa856d9b05358 | |
| ToppCell | VE-mono2|VE / Condition, Cell_class and T cell subcluster | 2.02e-05 | 180 | 40 | 4 | 494d00672f20ceffa7054a31e617fb7ec72e56e9 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.02e-05 | 180 | 40 | 4 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.07e-05 | 181 | 40 | 4 | 66d890a105f955dca91d6e5e6c730d1a68ee9233 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.07e-05 | 181 | 40 | 4 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pre-pDC/DC5|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 182 | 40 | 4 | 748401d2c84260a777001dd75b0182453185addc | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.21e-05 | 184 | 40 | 4 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 2.25e-05 | 185 | 40 | 4 | 23ffba9216729b5bdb30b35742ba2627bb1200bf | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.35e-05 | 187 | 40 | 4 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 2.40e-05 | 188 | 40 | 4 | 239a2162a21d3339da7c1884ab76286346fbf97f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-05 | 188 | 40 | 4 | 6b0e0192519ea3ca49fb21de3da9a0a108fcb64d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-05 | 188 | 40 | 4 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-05 | 188 | 40 | 4 | 0b19c35fdc2b9e064e8f03ef69ae08644794ec24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-05 | 189 | 40 | 4 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-05 | 189 | 40 | 4 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-05 | 190 | 40 | 4 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.50e-05 | 190 | 40 | 4 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-05 | 190 | 40 | 4 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-05 | 190 | 40 | 4 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-05 | 190 | 40 | 4 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-05 | 190 | 40 | 4 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.60e-05 | 192 | 40 | 4 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 193 | 40 | 4 | c6633aca0eb4d699c4d3da3199b84bebd87e2d31 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-05 | 193 | 40 | 4 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 193 | 40 | 4 | bdbbfcbe339f23a88dfcc59d53c034bac1605b07 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 193 | 40 | 4 | acafe177cd05b2966f5fa26ea02f420f13f2cee5 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 193 | 40 | 4 | a32791b4bdb7c5f2b4cc75b660321ab75c4fac9b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-05 | 193 | 40 | 4 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-05 | 193 | 40 | 4 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-05 | 194 | 40 | 4 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 194 | 40 | 4 | 66dd0469db797c61b094f47426b5212fe52156e9 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.71e-05 | 194 | 40 | 4 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 194 | 40 | 4 | 840220fe357e6e79fb60a530798be2dc12ce8f32 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 194 | 40 | 4 | ccb04f0788c98e0f63f18b09484d75ac536412a1 | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|erythropoietic / Lineage and Cell class | 2.77e-05 | 195 | 40 | 4 | cd3d8fa6e18c0508cdfb64bb879d90b211badee5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-05 | 195 | 40 | 4 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 195 | 40 | 4 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | (4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.88e-05 | 197 | 40 | 4 | dd9abb43c23e7698433e455eacbf5b23b0a756c2 | |
| ToppCell | (4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.88e-05 | 197 | 40 | 4 | 1b82979a41ef46c814c82527a585900586d71260 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 197 | 40 | 4 | 0de77f04612b66cc637dab5d5432c6e711e5964e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 197 | 40 | 4 | a01640e31fc33c1ab512b4d3eddae8342ecf182c | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 198 | 40 | 4 | 1637a255b67527fc9f9eb5352fb81cda9168fdfb | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-B_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.94e-05 | 198 | 40 | 4 | 3f8c24295ea98c9fbcad2dc5fee17851197e60b3 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 198 | 40 | 4 | 232905d61002fc552e2a8920167dceb550e8eec6 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-05 | 198 | 40 | 4 | b090c28336b4a0f9acab192885d9c2c2cc5d36e7 | |
| ToppCell | Sepsis-Leuk-UTI-Others|Leuk-UTI / Disease, condition lineage and cell class | 3.00e-05 | 199 | 40 | 4 | e45fe91f1d1c47a305b0f39d808730723852af00 | |
| ToppCell | Control-Control-Others-RBC|Control / Disease, condition lineage and cell class | 3.00e-05 | 199 | 40 | 4 | eb4c52d04f572433c0239bf479d0040a309939a1 | |
| ToppCell | Sepsis-Leuk-UTI-Others-RBC|Leuk-UTI / Disease, condition lineage and cell class | 3.00e-05 | 199 | 40 | 4 | d9b517199a646c9461c615412ad5b58cf4bed7c8 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 199 | 40 | 4 | f4fdf94c561dca35bb17766d908c5030655f43eb | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 199 | 40 | 4 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 946d904a880c0e211861fcec7e120853ffade282 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 199 | 40 | 4 | c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | 9f889f7ff0b3ba2750aa757b94680a9f7014fd0d | |
| ToppCell | Biopsy_Other_PF|World / Sample group, Lineage and Cell type | 3.05e-05 | 200 | 40 | 4 | fc41a9fb855ae5a5c73a769f18ec7a14f42f18ec | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.05e-05 | 200 | 40 | 4 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | 06ffa5baad3e699cf66d8b2c7513649e1d2c7e62 | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | Control-CD8+_T|Control / Disease group and Cell class | 8.78e-05 | 96 | 40 | 3 | 14e53fd2df39ac9d0b9cdc8b7ca2e95e53ac8bfe | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 109 | 40 | 3 | 6e90d04c5094c7410d667dae80de3279bddd24bd | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 126 | 40 | 3 | 197d2c836ae46a5c67f68d10c71ba86b7b40b59d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-04 | 128 | 40 | 3 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-04 | 131 | 40 | 3 | d76a7a9b50ee6d24b74494c6f6b88b3506b3f9ad | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.25e-04 | 132 | 40 | 3 | c07842a4b514f1e950c8af303f3b6b4275906e6a | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-04 | 135 | 40 | 3 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.51e-04 | 137 | 40 | 3 | 86c32cd26fe3b23c1dcd8ace580231c5a6ec6d9e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.51e-04 | 137 | 40 | 3 | 8989103606b15dff300e44c1590cd867b3cf7833 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-04 | 139 | 40 | 3 | c320847311ba9a844fc4760251372a2a9152787b | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 140 | 40 | 3 | 731b46e4b815a45af1d0ce7ab4d0d0324ac8798f | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 140 | 40 | 3 | b30fc389583406ee6cb55112d0f7250d1b74c88a | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 140 | 40 | 3 | 35ecd887bb7827603ef673912ba820208a6368d2 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-04 | 140 | 40 | 3 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.68e-04 | 140 | 40 | 3 | 3f003320d797f18d2dfc38eab7f094f75027958e | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.79e-04 | 142 | 40 | 3 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.79e-04 | 142 | 40 | 3 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-04 | 143 | 40 | 3 | 4122dcb742d3c8deff552b4dae9f2d239e6828f3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.44e-06 | 50 | 23 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Genes in the cancer module 293. | 2.85e-04 | 12 | 23 | 2 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 3.92e-04 | 14 | 23 | 2 | MODULE_143 | |
| Drug | Palladium | 1.89e-07 | 7 | 41 | 3 | ctd:D010165 | |
| Disease | extranodal nasal NK/T cell lymphoma | 4.60e-08 | 6 | 40 | 3 | MONDO_0019472 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.29e-07 | 8 | 40 | 3 | DOID:0060072 (implicated_via_orthology) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 3.78e-07 | 11 | 40 | 3 | DOID:0080822 (is_implicated_in) | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 1.79e-06 | 2 | 40 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | hepatitis B virus infection | 2.20e-06 | 19 | 40 | 3 | EFO_0004197 | |
| Disease | Anti-rubella virus IgG measurement | 5.37e-06 | 3 | 40 | 2 | EFO_0009357 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 5.37e-06 | 3 | 40 | 2 | DOID:639 (is_implicated_in) | |
| Disease | Aspirin-induced asthma | 5.37e-06 | 3 | 40 | 2 | HP_0012042 | |
| Disease | Anti-hepatitis B virus surface antigen IgG measurement, response to vaccine | 5.37e-06 | 3 | 40 | 2 | EFO_0004645, EFO_0009358 | |
| Disease | anti-basement membrane glomerulonephritis (is_implicated_in) | 1.07e-05 | 4 | 40 | 2 | DOID:4780 (is_implicated_in) | |
| Disease | allergic asthma (is_implicated_in) | 1.79e-05 | 5 | 40 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 1.79e-05 | 5 | 40 | 2 | EFO_0801672 | |
| Disease | response to vaccine | 2.27e-05 | 122 | 40 | 4 | EFO_0004645 | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 2.68e-05 | 6 | 40 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | Angioedema | 2.68e-05 | 6 | 40 | 2 | C0002994 | |
| Disease | Achalasia | 3.75e-05 | 7 | 40 | 2 | HP_0002571 | |
| Disease | narcolepsy (is_implicated_in) | 3.75e-05 | 7 | 40 | 2 | DOID:8986 (is_implicated_in) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.07e-05 | 49 | 40 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Sarcoidosis | 4.99e-05 | 8 | 40 | 2 | C0036202 | |
| Disease | interleukin-21 measurement | 4.99e-05 | 8 | 40 | 2 | EFO_0801724 | |
| Disease | hepatitis B virus infection, Susceptibility to viral and mycobacterial infections | 4.99e-05 | 8 | 40 | 2 | EFO_0004197, Orphanet_391311 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 6.41e-05 | 9 | 40 | 2 | EFO_0007790 | |
| Disease | central nervous system non-hodgkin lymphoma | 6.41e-05 | 9 | 40 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 6.41e-05 | 9 | 40 | 2 | EFO_0801686 | |
| Disease | Sjogren syndrome | 7.48e-05 | 60 | 40 | 3 | EFO_0000699 | |
| Disease | C-C motif chemokine 21 measurement | 8.01e-05 | 10 | 40 | 2 | EFO_0008048 | |
| Disease | CCL19 measurement | 8.01e-05 | 10 | 40 | 2 | EFO_0009415 | |
| Disease | childhood onset asthma | 8.57e-05 | 334 | 40 | 5 | MONDO_0005405 | |
| Disease | Allergic Reaction | 8.66e-05 | 63 | 40 | 3 | C1527304 | |
| Disease | Hypersensitivity | 9.08e-05 | 64 | 40 | 3 | C0020517 | |
| Disease | susceptibility to hepatitis B infection measurement | 9.08e-05 | 64 | 40 | 3 | EFO_0008405 | |
| Disease | carcinoma (implicated_via_orthology) | 9.08e-05 | 64 | 40 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Berylliosis | 9.78e-05 | 11 | 40 | 2 | C0005138 | |
| Disease | interleukin 1 receptor-like 1 measurement | 9.78e-05 | 11 | 40 | 2 | EFO_0008168 | |
| Disease | Beryllium Disease | 9.78e-05 | 11 | 40 | 2 | C2350873 | |
| Disease | gut microbiome measurement, taxonomic microbiome measurement | 9.95e-05 | 66 | 40 | 3 | EFO_0007874, EFO_0007883 | |
| Disease | dermatomyositis | 1.17e-04 | 12 | 40 | 2 | EFO_0000398 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.17e-04 | 12 | 40 | 2 | EFO_0009273 | |
| Disease | multiple sclerosis (is_implicated_in) | 1.34e-04 | 73 | 40 | 3 | DOID:2377 (is_implicated_in) | |
| Disease | autoimmune hepatitis (is_implicated_in) | 1.38e-04 | 13 | 40 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | Granulomatosis with Polyangiitis | 1.38e-04 | 13 | 40 | 2 | EFO_0005297 | |
| Disease | icos ligand measurement | 1.38e-04 | 13 | 40 | 2 | EFO_0020460 | |
| Disease | C-C motif chemokine 19 measurement | 1.61e-04 | 14 | 40 | 2 | EFO_0008047 | |
| Disease | liver neoplasm | 1.86e-04 | 15 | 40 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 1.86e-04 | 15 | 40 | 2 | EFO_0006927 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.86e-04 | 15 | 40 | 2 | EFO_0009935 | |
| Disease | interleukin 18 receptor 1 measurement | 1.86e-04 | 15 | 40 | 2 | EFO_0008178 | |
| Disease | Urticaria | 2.12e-04 | 16 | 40 | 2 | C0042109 | |
| Disease | gastroparesis | 2.12e-04 | 16 | 40 | 2 | EFO_1000948 | |
| Disease | osteoarthritis | 2.30e-04 | 222 | 40 | 4 | MONDO_0005178 | |
| Disease | anti-anoctamin 2 antibody measurement | 2.41e-04 | 17 | 40 | 2 | EFO_0010150 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 2.41e-04 | 17 | 40 | 2 | EFO_0010559, GO_0035456 | |
| Disease | susceptibility to plantar warts measurement | 2.50e-04 | 90 | 40 | 3 | EFO_0008406 | |
| Disease | late-onset myasthenia gravis | 2.70e-04 | 18 | 40 | 2 | EFO_1001490 | |
| Disease | leprosy, Crohn's disease | 3.35e-04 | 20 | 40 | 2 | EFO_0000384, EFO_0001054 | |
| Disease | ST2 protein measurement | 3.70e-04 | 21 | 40 | 2 | EFO_0010599 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 4.07e-04 | 22 | 40 | 2 | EFO_0021881 | |
| Disease | Henoch-Schoenlein purpura | 4.07e-04 | 22 | 40 | 2 | EFO_1000965 | |
| Disease | cancer (implicated_via_orthology) | 4.70e-04 | 268 | 40 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | chronic hepatitis B virus infection | 4.85e-04 | 24 | 40 | 2 | EFO_0004239 | |
| Disease | adult onset asthma | 5.53e-04 | 118 | 40 | 3 | EFO_1002011 | |
| Disease | corpus callosum central volume measurement | 6.62e-04 | 28 | 40 | 2 | EFO_0010296 | |
| Disease | respiratory failure, COVID-19 | 7.11e-04 | 29 | 40 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | self rated health | 8.13e-04 | 31 | 40 | 2 | EFO_0004778 | |
| Disease | heart conduction disease (implicated_via_orthology) | 8.66e-04 | 32 | 40 | 2 | DOID:10273 (implicated_via_orthology) | |
| Disease | bullous pemphigoid | 9.78e-04 | 34 | 40 | 2 | EFO_0007187 | |
| Disease | dementia, Alzheimer's disease neuropathologic change | 9.78e-04 | 34 | 40 | 2 | EFO_0006801, MONDO_0001627 | |
| Disease | asthma (is_implicated_in) | 1.26e-03 | 157 | 40 | 3 | DOID:2841 (is_implicated_in) | |
| Disease | Graves' disease (is_implicated_in) | 1.29e-03 | 39 | 40 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | factor VIII measurement | 1.35e-03 | 40 | 40 | 2 | EFO_0004630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEGLFPGVIDLFGGL | 156 | Q14032 | |
| VPVGVGIAGALFILG | 716 | Q86TY3 | |
| GEGIFISFILAGGPA | 486 | Q12959 | |
| GGFVLGLIICGVGIF | 231 | P04440 | |
| FPVFGEGEGVLLVGV | 166 | Q9H790 | |
| FIFYILGLGIHGIGG | 211 | Q9Y5S8 | |
| FGVLPGLVGVGGVVQ | 361 | Q8NCK7 | |
| GVGGFVLGLLFLGAG | 231 | Q30154 | |
| SGVGFILGPVVGGYL | 176 | Q8NBP5 | |
| FPRLGVIGFAGLIGL | 111 | Q9BUR5 | |
| ICGGGLEPGLVFLGF | 456 | Q02846 | |
| VDVGPLLLVPGGFFG | 216 | Q9HAT1 | |
| GIPLFGFLLAGVGDQ | 181 | O95069 | |
| LLGFVGPGSLVFVVG | 796 | Q9P265 | |
| GIPLFGFLLAGIGDQ | 191 | P57789 | |
| GVGITGFGIFFILFG | 11 | Q6ZVE7 | |
| FERGIPVFGTLVAGG | 361 | Q6NXR0 | |
| LFDVGGIFGGILAGV | 371 | P57057 | |
| GVGGFVLGLLFLGAG | 231 | P79483 | |
| GPVLFAVGGGSLFAI | 341 | Q6TDP4 | |
| LRGEPFIRGGGAGFI | 371 | P10643 | |
| GLLGFVGPGGLVFVV | 776 | Q9Y2E4 | |
| GVGGFVLGLLFLGAG | 231 | P01911 | |
| VEAGGGGAFIVLPLA | 51 | Q6QEF8 | |
| GEGIFVSFILAGGPA | 406 | Q92796 | |
| GVGGFVLGLLFLGTG | 231 | P13762 | |
| GGVFFILGGLLGFIP | 121 | P57739 | |
| GEGIFVSFILAGGPA | 441 | Q15700 | |
| LVALLGGGLPAGFVG | 41 | Q96KT7 | |
| LVALLGGGLPAGFVG | 41 | Q8N808 | |
| GIILGFGSFLGIIGI | 61 | Q8WV15 | |
| GGGPFTLAGILFGNI | 31 | Q8IZX4 | |
| IVVGLGGVLFGIVFG | 271 | Q6AI14 | |
| GEGFILGGVFVVGSG | 176 | Q9BRX8 | |
| LKALGTGFGIIPVGG | 151 | Q96H20 | |
| LPAFAVIGIASGFGG | 321 | P51788 | |
| GVSVAFGAPIGGVLF | 321 | P51790 | |
| LVALLGGGLPAGFVG | 41 | P0C7Q5 | |
| VGIGGVLIGIFLGFI | 281 | Q9UBY0 | |
| LVALLGGGLPAGFVG | 41 | P0C7Q6 | |
| GLGGGFRQPLGAIVA | 216 | Q9BXU2 | |
| LVGFPLTVIGGIFGK | 421 | O15321 |